PROCEPT BioRobotics (PRCT) EBITDA Margin (2020 - 2026)
PROCEPT BioRobotics (PRCT) posted quarterly EBITDA Margin of 39.22% for Q1 2026, up 45.0% year-over-year from 27.05% in Q1 2025, and up 3.49% quarter-over-quarter from 40.64% in Q4 2025.
PROCEPT BioRobotics (PRCT) EBITDA Margin (2020 - 2026) Analysis & Trends
PROCEPT BioRobotics (PRCT) has reported EBITDA Margin for 7 consecutive years, with 39.22% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA Margin rose 45.0% year-over-year to 39.22%; the TTM figure through Mar 2026 stood at 33.86% (up 484.0% YoY), while the FY2025 annual figure was 33.71%, up 932.0% from the prior year.
- EBITDA Margin improved to 39.22% in Q1 2026 per PRCT's latest filing, from 40.64% in the prior quarter.
- Across five years, EBITDA Margin topped out at 27.83% in Q3 2025 and bottomed at 116.28% in Q1 2023.
- Historically, EBITDA Margin has averaged 65.95% across 5 years, with a median of 62.08% in 2024.
- Annual changes were most pronounced in 2022 — EBITDA Margin soared 6071 bps — and 2025, when it sank 1175 bps.
- PROCEPT BioRobotics' EBITDA Margin stood at 105.31% in 2022, then soared by 36 bps to 67.82% in 2023, then jumped by 57 bps to 28.89% in 2024, then sank by 41 bps to 40.64% in 2025, then advanced by 3 bps to 39.22% in 2026.
- Business Quant data shows PRCT's EBITDA Margin at 39.22% in Q1 2026, 40.64% in Q4 2025, and 27.83% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.12 Bn | 195.52 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 126.68 Bn | 123.20 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 118.99 Bn | 109.77 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.75 Bn | 47.50 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.78 Bn | 32.83 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.73 Bn | 31.62 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.23 Bn | 22.91 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 19.15% |
| 10 | PROCEPT BioRobotics | 1.23 Bn | 952.43 Mn | 62.38 Mn | -28.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -28.98% |
| Mar 31, 2026 | -39.22% |
| Dec 31, 2025 | -40.64% |
| Sep 30, 2025 | -27.83% |
| Jun 30, 2025 | -28.02% |
| Mar 31, 2025 | -39.67% |
| Dec 31, 2024 | -28.89% |
| Sep 30, 2024 | -38.42% |
| Jun 30, 2024 | -50.28% |
| Mar 31, 2024 | -62.08% |
| Dec 31, 2023 | -67.82% |
| Sep 30, 2023 | -72.96% |
| Jun 30, 2023 | -77.41% |
| Mar 31, 2023 | -116.28% |
| Dec 31, 2022 | -105.31% |
| Sep 30, 2022 | -108.63% |
| Jun 30, 2022 | -107.09% |
| Mar 31, 2022 | -110.61% |
| Dec 31, 2021 | -166.02% |
| Sep 30, 2021 | -147.63% |